Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
24.20
+1.51 (6.65%)
At close: Oct 8, 2025, 4:00 PM EDT
24.35
+0.15 (0.62%)
After-hours: Oct 8, 2025, 7:55 PM EDT
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $1.45 billion as of October 8, 2025. Its market cap has decreased by -44.53% in one year.
Market Cap
1.45B
Enterprise Value
480.45M
1-Year Change
-44.53%
Ranking
Category
Stock Price
$24.20
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $1.45B, an increase of 136.96%. That is a compound annual growth rate of 22.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 1.45B | -52.89% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
| Jun 11, 2021 | 613.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.23B |
| Johnson & Johnson | 456.84B |
| AbbVie | 408.50B |
| UnitedHealth Group | 335.03B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.69B |